Advertisements



From Zit to Zip: Valeant Rises on Acne Drug Application

Valeant is rising on news that the FDA accepted the application of one of its acne drugs, with an approval decision date set for August......»»

Category: blogSource: barronsJan 12th, 2018

FDA Accepts Allergan and Paratek’s Newest Acne Treatment for Review

Paratek Pharmaceuticals saw its shares make a handy gain on Thursday after the firm announced that the FDA accepted its New Drug Application for the review of Seysara for the treatment of moderate to........»»

Category: blogSource: 247wallstDec 21st, 2017

Allergan/Paratek"s Acne Candidate NDA Filing Accepted by FDA

Allergan (AGN) and partner Paratek announces that its new drug application for Seysara has been .....»»

Category: smallbizSource: nytDec 21st, 2017

Allergan marketing application for acne drug accepted by FDA

Allergan PLC shares ticked higher in th.....»»

Category: topSource: marketwatchDec 20th, 2017

Valeant"s (VRX) NDA for Bowel Cleansing Drug Accepted by FDA

Valeant Pharmaceuticals International, Inc.'s (VRX) wholly owned subsidiary, Salix Pharmaceuticals, announced that the FDA has accepted its New Drug Application for Plenvu. .....»»

Category: topSource: zacksJun 29th, 2017

Rigel Pharma Rises Following FDA Approval

Rigel Pharmaceuticals watched its shares make a handy uptick on Monday after the FDA approved its New Drug Application for the use of Tavalisse in patients with chronic or persistent immune........»»

Category: blogSource: 247wallstJun 19th, 2017

Perrigo says it has filed for FDA approval for a generic version of Valeant"s acne gel

Perrigo Co. said early Tuesday that it has filed for Food and Drug Administration approval for a generic version of Valeant Pha.....»»

Category: topSource: marketwatchFeb 7th, 2017

2017 Q4 mortgage fraud risk rises slightly

The national mortgage application fraud risk index rose from 135 in the third quarter of 2017 to 138 in the fourth quarter, according to researchers at CoreLogic. .....»»

Category: topSource: usatodayJan 19th, 2018

2017 Q4 Mortgage Fraud Risk Rises Slightly

Mortgage application fraud risk rose again in the fourth quarter of 2017 according to data released Thursday by research firm CoreLogic. The report includes a list of 15 metro areas were the risks........»»

Category: blogSource: 247wallstJan 18th, 2018

More USFDA approvals do not mean better margins for Indian "big pharma"

Indian pharma firms including their subsidiaries have received around 304 abbreviated new drug application approvals from the USFDA in 2017.....»»

Category: topSource: business-standardJan 10th, 2018

Achaogen"s NDA for Plazomicin Gets Priority Review From FDA

Achaogen's (AKAO) NDA for its urinary tract infections candidate, plazomicin, gets FDA's priority review. Achaogen, Inc. AKAO announced that the FDA has accepted its new drug application (“NDA”) for i.....»»

Category: worldSource: nytJan 3rd, 2018

Trevena shares rally as FDA accepts painkiller marketing application for review

Trevena Inc. shares jumped in the extended session Tuesday after the biotech company said the Food and Drug Administration accepted for review a marketing application for i.....»»

Category: topSource: marketwatchJan 2nd, 2018

Progenics Pharma Surges on FDA Decision

Progenics Pharmaceuticals saw its shares make a solid gain to close out the year after the FDA accepted for review the firm’s New Drug Application (NDA) for Azedra......»»

Category: blogSource: 247wallstDec 29th, 2017

Sun Pharma"s specialty business gets USFDA boost

Stock gained over 6% as FDA accepts application for new ophthalmic drug.....»»

Category: topSource: business-standardDec 27th, 2017

Sun Pharma shares rise over 6% after USFDA accepts new drug application

The stock closed at 6.12 per cent to Rs 573.50 on BSE.....»»

Category: topSource: business-standardDec 27th, 2017

Sun Pharma up 4% on USFDA acceptance of new drug application

The stock was up 4% at Rs 564 on the BSE with trading volumes on the counter more than doubled......»»

Category: topSource: business-standardDec 27th, 2017

USFDA accepts Sun Pharma"s new eye drug application

Shares of Sun Pharma were up 5.75 per cent at Rs 571.55 on the BSE.....»»

Category: topSource: business-standardDec 27th, 2017

Cancer Drug Price Rises 1400% With No Generic to Challenge It

Since 2013, the price of a 40-year-old, off-patent cancer drug in the U.S. has risen 1,400%, putting the life-extending medicine out of reach for some patients......»»

Category: topSource: moneycentralDec 26th, 2017

Cancer Drug Price Rises 1,400% With No Generic to Challenge It

Since 2013, the price of a 40-year-old, off-patent cancer drug in the U.S. has risen 1,400%, putting the life-extending medicine out of reach for some patients......»»

Category: topSource: wsjDec 25th, 2017

Shire"s New Formulation of Oncaspar Gets Approval in Europe

Shire's (SHPG) marketing authorization application for a new (dried) formulation of its leukemia drug, Oncaspar receives approval from the European Commission. Shire plc SHPG announced that the European Commission (“EC”) has grante.....»»

Category: smallbizSource: nytDec 14th, 2017

Merck"s Keytruda Gets FDA Priority Review for Rare Lymphoma

Merck (MRK) informs that the FDA grants a priority review to its supplemental biologics license application looking for its marketed drug Keytruda's label expansion for a rar.....»»

Category: worldSource: nytDec 12th, 2017